CAD 0.05
(-9.09%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -105.24 Million USD | 74.72% |
2022 | -416.24 Million USD | -277.15% |
2021 | -110.36 Million USD | -48.95% |
2020 | -74.09 Million USD | 20.23% |
2019 | -92.89 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | -10.73 Million USD | 86.61% |
2024 Q2 | 8 Million USD | 174.91% |
2023 Q4 | -77.69 Million USD | -301.91% |
2023 FY | -105.24 Million USD | 74.72% |
2023 Q3 | -19.33 Million USD | -39548.98% |
2023 Q2 | 49 Thousand USD | 100.59% |
2023 Q1 | -8.26 Million USD | 97.71% |
2022 Q2 | -22.1 Million USD | -50.75% |
2022 Q1 | -14.66 Million USD | 87.88% |
2022 FY | -416.24 Million USD | -277.15% |
2022 Q4 | -360.75 Million USD | -1828.15% |
2022 Q3 | -18.71 Million USD | 15.37% |
2021 FY | -110.36 Million USD | -48.95% |
2021 Q2 | 2.31 Million USD | 192.93% |
2021 Q1 | -2.48 Million USD | 90.78% |
2021 Q4 | -120.98 Million USD | -1221.02% |
2021 Q3 | 10.79 Million USD | 366.58% |
2020 Q4 | -27 Million USD | -519.74% |
2020 FY | -74.09 Million USD | 20.23% |
2020 Q3 | -4.35 Million USD | 81.66% |
2020 Q1 | -18.97 Million USD | -14.41% |
2020 Q2 | -23.76 Million USD | -25.2% |
2019 Q4 | -16.58 Million USD | 8.56% |
2019 FY | -92.89 Million USD | 0.0% |
2019 Q3 | -18.14 Million USD | 46.7% |
2019 Q2 | -34.03 Million USD | -9707.51% |
2019 Q1 | 354.25 Thousand CAD | 0.0% |
2018 Q3 | - USD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Filament Health Corp. | -4.3 Million CAD | -2346.07% |